Cargando…

Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia

OBJECTIVES: This study aimed to define the problems of the current use of the e-Catalogue and the national formulary (NF)—two elements of medicine pricing and reimbursement policies in Indonesia for achieving universal health coverage (UHC)—by examining the knowledge and attitudes of stakeholders. S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wasir, Riswandy, Irawati, Sylvi, Makady, Amr, Postma, Maarten, Goettsch, Wim, Buskens, Erik, Feenstra, Talitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380537/ https://www.ncbi.nlm.nih.gov/pubmed/30779809 http://dx.doi.org/10.1371/journal.pone.0212328

Ejemplares similares

The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders
por: Wasir, Riswandy, et al.
Publicado: (2019)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
por: Gray, Andrew L
Publicado: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
por: Tsai, Hsin-Yi, et al.
Publicado: (2022)

Cost-Effectiveness of Four Tobacco Control Interventions in Mongolia
por: Tuvdendorj, Ariuntuya, et al.
Publicado: (2023)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
por: Docteur, Elizabeth, et al.
Publicado: (2015)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
por: Dahmani, Hajer, et al.
Publicado: (2023)

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
por: Callenbach, Marcelien H. E., et al.
Publicado: (2022)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluations
por: Tuvdendorj, Ariuntuya, et al.
Publicado: (2020)

Smoking-attributable burden of lung cancer in Mongolia a data synthesis study on differences between men and women
por: Tuvdendorj, Ariuntuya, et al.
Publicado: (2020)

Physician pricing and health insurance reimbursement
por: Yett, Donald E., et al.
Publicado: (1983)

More than cost‐effectiveness? Applying a second‐stage filter to improve policy decision making
por: Kan, Kaying, et al.
Publicado: (2021)

Stratified Medicine and Reimbursement Issues
por: Fugel, Hans-Joerg, et al.
Publicado: (2012)

Use of Social Media in the Assessment of Relative Effectiveness: Explorative Review With Examples From Oncology
por: Kalf, Rachel RJ, et al.
Publicado: (2018)

Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014)

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)

The costs of inappropriate referral pathways in inpatient care for three major noncommunicable diseases in Mongolia: a national registry-based analysis
por: Tuvdendorj, Ariuntuya, et al.
Publicado: (2021)

Burden and Cost of Anterior Cruciate Ligament Reconstruction and Reimbursement of Its Treatment in a Developing Country: An Observational Study in Indonesia
por: Deviandri, Romy, et al.
Publicado: (2022)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
por: Kamphuis, Bregtje W., et al.
Publicado: (2021)

Pricing and reimbursement of orphan drugs: the need for more transparency
por: Simoens, Steven
Publicado: (2011)

Drug pricing and reimbursement decision making systems in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2017)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
por: Kawalec, Paweł, et al.
Publicado: (2017)

The timelines for the price and reimbursement authorization in Italy 2018–2020
por: Gallo, Valentina, et al.
Publicado: (2022)

Key factors influencing the prescribing of statins: a qualitative study among physicians working in primary healthcare facilities in Indonesia
por: Irawati, Sylvi, et al.
Publicado: (2020)

The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
por: Scheijmans, Féline E. V., et al.
Publicado: (2022)

Impact of price and non-price policies on household cigarette consumption and nutrient intake in smoking-tolerant Indonesia
por: Djutaharta, Triasih, et al.
Publicado: (2021)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015)

Indonesia's road to universal health coverage: a political journey
por: Pisani, Elizabeth, et al.
Publicado: (2017)

Pre-reimbursement: early assessment for coverage decisions
por: Grössmann, Nicole, et al.
Publicado: (2019)

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
por: Drummond, Michael, et al.
Publicado: (2010)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
por: Vitry, Agnes
Publicado: (2015)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
por: Elvira, David, et al.
Publicado: (2023)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
por: Macabeo, Bérengère, et al.
Publicado: (2023)

Reducing the Burden of Disease Through Tobacco Taxes in Mongolia: A Health Impact Analysis Using a Dynamic Public Health Model
por: Tuvdendorj, Ariuntuya, et al.
Publicado: (2021)

Mapping chronic disease prevalence based on medication use and socio-demographic variables: an application of LASSO on administrative data sources in healthcare in the Netherlands
por: Füssenich, Koen, et al.
Publicado: (2021)

Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals
por: Carlson, Josh, et al.
Publicado: (2009)

Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
por: Atikeler, Enver Kagan, et al.
Publicado: (2016)

Reimbursement pricing for new medical devices in Japan: Is the evaluation of innovation appropriate?
por: Tamura, Makoto, et al.
Publicado: (2018)

Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study
por: Makady, Amr, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v6voahd8mh802l6h6ufmft660e